100%

Scanned image of the page. Keyboard directions: use + to zoom in, - to zoom out, arrow keys to pan inside the viewer.

Page Options

Download this Issue

Share

Something wrong?

Something wrong with this page? Report problem.

Rights / Permissions

This collection, digitized in collaboration with the Michigan Daily and the Board for Student Publications, contains materials that are protected by copyright law. Access to these materials is provided for non-profit educational and research purposes. If you use an item from this collection, it is your responsibility to consider the work's copyright status and obtain any required permission.

October 09, 2002 - Image 10

Resource type:
Text
Publication:
The Michigan Daily, 2002-10-09

Disclaimer: Computer generated plain text may have errors. Read more about this.

4

10 - The Michigan Daily - Wednesday, October 9, 2002

Big 12 powers meet in Red River showdown

NATION
Continued from Page 8
No. 2 OKLAHOMA AT No. 3 TEXAS, 3:30 P.M.:
Last week saw a "Twilight Zone"-like scenario
unfold in the Big 12, with Oklahoma and Texas
nearly falling to Missouri and Oklahoma State,
respectively. The Sooners and Longhorns man-
aged to escape with wins, and any money says
that both teams were looking ahead to this week's
tremendously important Red River Shootout in
Dallas.
The Texas defense comes into this game as one
of the top-rated units in the country. This, com-
bined with a mediocre Oklahoma offense, seem-
ingly adds up to a Texas win. But, the Longhorns
always seem to struggle in big games like this,
and quarterback Chris Simms will need to step
up to change the trend.
Given his past performance in such situations,
this -is not likely to happen. Oklahoma quarter-
back Nate Hybl (who has yet to throw an inter-
ception this season) will instead take the
initiative and lead his Sooners to victory. Unfor-
tunately, this game will not be seen on television
locally because of the Michigan-Penn State
game. Saturday will definitely be a good time to
befriend that weird guy next door who owns a
satellite dish, because this one promises to be a
dandy.
Oklahoma 20, Texas 17
No. 6 GEORGIA vs. No. 10 TENNESSEE, 3:30
P.M., CBS: Both the Bulldogs and Volunteers are
coming off very close calls last week. Georgia
proved its resolve after it blew a 12 point lead at
Alabama and then came back-to win with a last-
minute field goal. Tennessee, on the other hand,
C decided it would be fun to play six overtimes
against Arkansas, and finally prevailed 41-38 in a
game that just ended this morning. Tennessee

comes in boasting talent at wide receiver in
standout Kelley Washington and a solid quarter-
back in Casey Clausen. Similarly, Georgia has a
good leader in signal-caller David Greene and
two top receivers in Fred Gibson and Terrence
Edwards. The outcome of this game will ulti-
mately hinge on the performance of Bulldogs
running back Musa Smith. If he has a big game
like he did last week (when he ran for 126 yards
and a touchdown), then Georgia can pull this one
off against a tough Tennessee squad. Look for
Smith to keep his momentum going and help the
'Dawgs pull out a close one in Athens.
Georgia 24, Tennessee 21

No. 18 LoUISIANA STATE AT No. 16 FLORIDA,
7:45 P.M., ESPN: The Gators are angry, and for
good reason: This year marks their quickest two-
defeat season in 10 years, and new coach Ron
Zook is seeing former Florida "ball coach" Steve
Spurrier and his orange visor in his nightmares.
To make matters worse, the team is out of the
national championship race for good after its loss
to Ole Miss last Saturday, in which quarterback
Rex Grossman threw four interceptions.
Louisiana State comes to The Swamp boasting a
4-1 record, but the Gators will take their anger
out on the Tigers and prevail in a shootout.
Florida 34, LSU 30

AP PHOTO
Texas's Chris Simms has led the Longhorns to a No. 3 ranking thus far, but faces
his biggest challenge yet with No. 2 Oklahoma coming to town.

AP PHOTO
Rex Grossman and his Florida teammates will be desperate for a win when they host LSU on Saturday. The
Gators are off to their worst start in 10 years, and Steve Spurrier is nowhere to be found.

[Do you Have Acne?
¢ If you have acne you may qualify for an investigational study
at the University of Michigan Department of Dermatology.
¢ You may also receive compensation for your participation.
¢ If you are interested in participating, call the University of
Michigan Department of Dermatology to find out more.
¢ The number is : (734) 764-DERM "
Free!
MCAT Strategy and Admissions Event
AMSA Pre- Medical Club is pleased to announce that Albert
Chen, the world's foremost authority on the MCAT, is returning
to the University of Michigan. Mr. Chen will be in Ann Arbor on
October 9 at 8:00pm at the MLB (auditorium 4) to present a free
MCAT and Medical Admissions Seminar.

'M' pumped for State Pride Series

By Albert Kim
Daily Sports Writer

Naming a rivalry is risky, unless peo-
ple know that it will be a good match
each and every year. In the case of vol-
leyball's State Pride Series, it's a pretty
safe bet.
Tonight, the Michigan volleyball
team will battle No. 18 Michigan State
at Cliff Keen Arena for a claim to vol-
leyball supremacy in the state, at least
until Michigan visits East Lansing
October 30.
Both Michigan and Michigan State
come into tonight's game with identical

3-1 Big Ten records. Not only that, but
all three wins for both teams also came
against Ohio State, Iowa and Indiana,
and both lost to No. 6 Minnesota. The
two teams' styles of play are very simi-
lar also.
"We're both very balanced, and play
a defensive and transition style," Michi-
gan coach Mark Rosen said. "They're a
little bit bigger than we are, but we're a
little faster than they are."
The Spartans are looking to avenge last
year's early season loss in Ann Arbor. Led
by hitter Sara Villwock and a balanced,
potent attack, the Spartans will present a
challenge to Michigan's defense.

"We're going to have to control the
ball, and run our offense well," Rosen
said. "Defensively they will take it to us
if we don't do that"
It won't be anything the Wolverines
haven't seen already, though. Michigan
has already faced two ranked Big Ten
teams in Minnesota and Ohio State, and
is off to its best Big Ten start in years.
The Wolverines' sweep of the 16th-
ranked Buckeyes last week gives them
momentum coming into tonight. The
start hasn't been the result of doing any-
thing different.
One thing that may favor Michigan
tonight is the luxury of having five
returning starters, including the
Wolverines' all time blocks leader
Katrina Lehman. In addition, the lone
new starter, setter Lisa Gamalski, has
grown quickly into her role, and is
ranked 23rd in the nation in assists
per game.
As long as Michigan can keep
SpaRTs BRIEFS

CLIFF KEEN ARENA
Who: Michigan (3-1 Big Ten, 9-5 overall) vs.
Michigan State (3-1, 11-3)
When: 7 p.m.
Latest: This is the first of two matches in the in
the annual State Pride Series. Michigan is look-
ing for its first victory in three years in the
event.
winning against top-25 opponents,
the Wolverines will have a good shot
at breaking into the rankings. This
week will prove crucial to Michi-
gan's chances.
With a logjam near the top of the Big
Ten standings going into this week,
Michigan could separate itself from the
rest of the pack with wins against the
Spartans, and Penn State on Friday.
It's for state pride tonight, but it's also
for sole possession of third place in the
Big Ten, and that's what matters to the
Wolverines.
"There's always extra motivation
playing against top rivals," Rosen
said. "But we compete to win the
conference."

4

ANN ARBOR REALTY
LOCATION - LOCATION - LOCATION
Central Campus
Efficiencies, 1, 2 & 3 bedroom apts.
Starting at $575/mo. Includes some utilities.
ANN ARBOR REALTY
616 CHURCH
(734) 663-7444
Open Mon-Fri, 9 am to 5:30 pm
arm a1r1

Kaplan is giving away over $10,000 in scholarships tonight!
To attend, you must register for this event by calling
(800) KAP-TEST or going online at kaptest.com!
1-800-KAP-TEST
kaptest.com
Test Prep, Admissions and Guidance. For life.
* MCAT is a registered trademark of the Association of American Medical Coleres.

Buffs on probation,
will lose scholarships
BOULDER, Colo. (AP) - Col-
orado's football team was placed on two
years' probation by the NCAA yester-
day for recruiting violations, most of
which occurred under former coach
Rick Neuheisel.
JOHN d CHRISTIAN
DESIGNERS & CRAFTSMEN SINCE 1850
Mich qar
COLLEGE MONOGRAM
RING
-YEAR DATE
-DEGREE
*GREEK LETTERS
-YOUR MONOGRAM

14K GOLD $450

Free Brochure

R I NG BOX.CO M 1-888-646-6466

The NCAA cut the school's foot-
ball scholarships and accepted Col-
orado's self-imposed recruiting limits,
including reducing the number of vis-
its by recruits.
Neuheisel, now head coach at Wash-
ington, was barred from off-campus
recruiting for the Huskies until May 31.
In Seattle, Washington athletics
spokesman Jim Daves had no immedi-
ate comment, but said the Huskies
planned to issue a statement.
Colorado was not banned from tele-
vision or bowl appearances but must
reduce the number of new scholarships
it offers from 25 to 20 in either the
2003-04 or 2004-05 academic year.
NCAA institutions are allowed 56
expense-paid campus visits by recruits
each academic year, but Colorado vol-
untarily reduced its number to 51 this
year and will be limited to 51 next year.
Terrell breaks foot,
might need surgery
LAKE FOREST, Ill. (AP) - The
Chicago Bears, already struck by
injuries to key players, have two more
- left guard Rex Tucker is out for the
season with a broken leg and former
Michigan wide receiver David Terrell
has a broken right foot that might need
surgery.
Terrell, the Bears' top draft pick in
2001, hurt his foot late in the fourth
quarter of Monday night's 34-21 loss
to the Green Bay Packers. He had a
stress fracture in that same foot his last
season at Michigan, but never missed
a game or a practice.
"We don't know what will happen
there right now," Jauron said yesterday.
"Our trainer and the doctors have to
talk about that some more to see what
needs to be done and what that will
mean to us and to David this year."
Terrell has only nine catches this
season, but three of those were for
touchdowns.

Contraceptive Injection

3irtk con-~trol you thinrk a~outt just L4- x a year

medroxyprogesterone acetate injectable suspension

DEPO-PROVERA* Contraceptive injection
(medroxyprogesterone acetate injectable suspension, USP)
This product is intended to prevent pregnancy. It does not protect against HIV
Infection (AIDS) and other sexuaHy transmitted diseases.
What Is DEPO-PROVERA Contraceptive Injection?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an
intramuscular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To
continue your contraceptive protection, you must return for your next injection promptly at the
end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a
chemical similar to (but not the same as) the natural hormone progesterone, which is produced
by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by
preventin your egg cells from ripening.Ifan egg is not released from the ovaries during your
menstrual cycle, it cannot become fertilized by sperm and result in pregnancy DEPO-PROVERA
also causes changes in the lining of your uterus that make it less likely or pregnancy to occur:
How effective is DEPO-PROVERA Contraceptive Injection?
The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the
recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROVERA
Contraceptive Injection?"). To make sure you are not pregnant when you first get
DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during
the first 5 days of a normal menstrual period; ONLY within the first 5 days after childbirth if not
breast-feeding; and, if exclusively breast-feeding. ONLY at the sixth week after childbirth. It is a
on rm in ectable contraceptive when administered at 3-month (13-week) intervals.
DEPO-PROVEPA Contraceptive Injection is over 99% effective, making it one of the most reliable
methods of birth control available. his means that the average annual pregnancy rate is less than
one for every I00 women who use DEPO-PROVEPA The effectiveness of most contraceptive
methods depends in part on how reliably each woman uses the method. The effectiveness of
DEPO-PROVEPA depends only on the patient returning every 3 months (O3 weeks)for her next
injection. Your health-care provider will help you compare DEPO-PROVEPA with other
contraceptive methods and give you the information you need in order to decide which
contraceptive method is the nght choice for you.
The following table shows the percent of women who got pregnant while using different kinds of
contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected
in women who use each method exactly as it should be used andthe typical rate of pregnancy
(which includes women who became pregnant because they orgot to use their birth control or
because they did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use

if you have had cancer of the breast
"if you have had a stroke
. if you have or have had blood clots (phlebitis) in your legs
" if you have problems with your liver or liver disease
" if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other
ingredients).
What other things should I consider before using DEPO-PROVERA
Contraceptive Injection?
You will have a physical examination before your doctor rescribes DEPO-PROVERA It is
important to tell your health-care provider if you have any ofthe following:
"a family history of breast cancer
- an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or
bleeding from your nipples
" kidney disease
" irregular or scanty menstrual periods
" high blood pressure
Smigraine headaches
"asthma
epilepsy (convulsions or seizures)
diabetes or a family history of diabetes
"a history of depression
if you are takin anyprescription or over-the-counter medications
This product is intended to prevent pregnancy. It does not~ protect against
transmission of HIV (AIDS) and other sexually transmitted diseases such as
chiamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
What If I want to become pregnant after using DEPO-PROVERA Contraceptive
Injection?
Because DEPO-PROVERA is a long-acting birth control methodit takes some time after your last
inection for its effect to wear offBased on the results from a large study done in the United States,
for women who stop using DEPO-PROVEPA in order to become pregnant it is expected that
about half of those who become pregnant will do so in about 10 months after their last injection;
about two thirds of those who become pregnant will do so in about 12 months; about 83% of
those who become pregnant will do so in about 15 months; and about 93% of those who become
renant will do so in about 18 months after their last injection. The length of time you use
O-PROVERA has no effect on how long ittakes ou to become pregnant after you stop using it
What are the risks of using DEPO-PROVERA Contraceptive Injection?
I rregulor Menstrual Bleeding
The side effect reported most frequently by women who use DEPO-PROVERA for
contraception is a change in their normal menstrual cycle. During the first year of using
DEPO-PROVERA, you might have one or more of the following changes: irregular or
unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding
at all. Unusually heavy or continuous bleeding, however is not a usual effect of DEPO-PROVERA;
and if this hap pens, you should see your health-care provider right away. With continued use of
DEPO-PROVE A, bleeding usually decreases, and many women stop having periods completely
In clinical studies of DEPO-PR OVEPA, 55% of the women studied reported no menstrual
bleeding (amenorrhea) after I year of use, ard 68% of the women studied reported no renstrual
bleeding after 2 years of use. The reason that your periods stop is because DEPO-PRO VEPA
causes a resting state in your ovaies. When your ovaries do not release an egg monthly the
regular monthly growth of the lining of your uterus does not occur and, therefore, the bleeding
that comes with your normal menstruation does not take place. When you stop using

6.Other Risks
Women who use hormone-based contraceptives may have an increased risk of blood clots or
stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin
to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should
tell your health-care provider if you have any of the problems listed in the next section.
What symptoms may signal problems while using DEPO-PROVERA
Contraceptive injection?
Call your health-care provider immediately if any of these problems occur following an injection
of DEPO-PROVEPA
+ sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot
in the lung)
" sudden severe headache or vomiting, dizziness or fainting, problems, with your eyesight or
speech, weakness, or numbness in an arm or leg (indicating a poss lle stroke)
severe pain or swelling in the calf (indicating a possible clot in the leg)
' unusually heavy vaginal bleeding
" severe pain or tenderness in the lower abdominal area
*persistent pain, pus, or bleeding at the inection site
What are the possible side effects of DEPO-PROVERA Contraceptive Injection?
I .Weight Gain
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of
the women who used DEPO-PROVEPA in clinical trials reported a weight gain of about 5 pounds
during the first year of use. You may continue to gain weight after the first yearWomen in one
large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over
those 2 years, or approximately 4 pounds per year Women who continued for 4 years gained an
average total of 13.8 pounds over those 4 years, or approximately 3. pounds per year Women
who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or
approximately 2.75 pounds per year
2. Oiler Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVEPA: Irregular menstrual bleeding, amenorrhea. headache, nervousness, abdominal
cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal
discharge or irritation, breast swellinguandetenderness, bloating, swelling of the hands or feet
backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot
flashes, and joint pain. Other problems were reported by very few of the women in the clinical
trials, but some of these could be senous. These include convulsions, jaundice, urinary tract
infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein
thrombosis, pulmonary embolus, breast cancer or cervical cancer If these or any other problems
occur during your use of DEPO-PROVERA, discuss them with your health-care provider.
Should any precautions be followed during use of DEPO-PROVERA
Contraceptive Injection?
I.Missed Periods
During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your
periods may stop completely If you have been receiving your DEPO-PROVEPA injections
regularly every 3 months (13 weeks), then you are probably not pregnant. Howeverif you think
that you may be pregnant, see your health-care provider
.Loboratory Test Inieroctions
If you are scheduled for any laboratory tests, tell your health-care provider that you are using
DEPO-PROVERA for contraception. Certain blood tests are affected by hormones such as
DEPO-PROVERA.
3.Drug Interacons

Lowest
Method Expected Typioal
DEPO-PROVERA 0.3 0.3
Impiants (Norplant) 02* 02
Femaie steiization 02 0A
Male sterilization 0 10.15
Oral contraceptive (pill) 3

Komisarek following
Cammalleri to minors
The Calgary Sun reported yesterday
that former Michigan defenseman
Mike Komisarek failed to make the
Montreal Canadiens' regular season
roster and will beigin the year in Hamil-

III

'A

Back to Top

© 2017 Regents of the University of Michigan